The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

If current trends continue, North America could soon become a hotspot for permanent measles transmission. Canada could lose ...

Three head physicians in the Outaouais have resigned in response to controversial new legislation that will change their pay, ...

Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while supply of ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

A new global health report suggests that every year from 2020 to 2024 about 1,400 deaths in Canada were associated with ...

While some Canadians may be nostalgic for a government-centred health-care system, in reality, other countries do universal ...

Yesterday, STAT’s Lizzy Lawrence and Adam Feuerstein scored another exclusive: The FDA’s top drug regulator has been placed ...

But the consumer sees no gain at checkout. Cloning is costly and yields no visible improvement in taste, nutrition or price.

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Canada eliminated measles in 1998. The U.S. followed two years later, in 2000. There are multiple criteria for losing an ...

Canada has tallied more than 5,000 cases this year, more than twice as many as the country recorded in the past 25 years ...